A study of almost 800 people who had cataract surgery in both eyes in one visit found no extraordinary safety issues, but that does not mean it’s suitable for everyone.

(Adnkronos Health) - "The important results of the Crossing study further support the broad potential of tezepelumab and its unique mechanism of action, which acts on TSLP at the origin of the ...

(Adnkronos) - "The one from 80 years ago is not a closed chapter in our history: there are families who have lost loved ones and there are people injured as children, as well as those injured by ...

Following the success achieved of reaching out to over 5.8 million individuals worldwide in its first year, a decree was passed by His Highness Sheikh Mohammed Bin Rashid Al Maktoum, launching the ...